In vivo induction of phase II detoxifying enzymes, glutathione transferase and quinone reductase by citrus triterpenoids by Perez, Jose L et al.
RESEARCH ARTICLE Open Access
In vivo induction of phase II detoxifying enzymes,
glutathione transferase and quinone reductase by
citrus triterpenoids
Jose L Perez1, Guddarangavvanahally K Jayaprakasha1, Adriana Cadena2, Elvia Martinez2, Hassan Ahmad1,2*†,
Bhimanagouda S Patil1*†
Abstract
Background: Several cell culture and animal studies demonstrated that citrus bioactive compounds have
protective effects against certain types of cancer. Among several classes of citrus bioactive compounds, limonoids
were reported to prevent different types of cancer. Furthermore, the structures of citrus limonoids were reported
to influence the activity of phase II detoxifying enzymes. The purpose of the study was to evaluate how variations
in the structures of citrus limonoids (namely nomilin, deacetyl nomilin, and isoobacunoic acid) and a mixture of
limonoids would influence phase II enzyme activity in excised tissues from a mouse model.
Methods: In the current study, defatted sour orange seed powder was extracted with ethyl acetate and subjected
to silica gel chromatography. The HPLC, NMR and mass spectra were used to elucidate the purity and structure of
compounds. Female A/J mice were treated with three limonoids and a mixture in order to evaluate their effect on
phase II enzymes in four different tissues. Assays for glutathione S-transferase and NAD(P)H: quinone reductase (QR)
were used to evaluate induction of phase II enzymatic activity.
Results: The highest induction of GST against 1-chloro-2,4-dinitrobenzene (CDNB) was observed in stomach
(whole), 58% by nomilin, followed by 25% isoobacunoic acid and 19% deacetyl nomilin. Deacetyl nomilin in
intestine (small) as well as liver significantly reduced GST activity against CDNB. Additionally isoobacunoic acid and
the limonoid mixture in liver demonstrated a significant reduction of GST activity against CDNB. Nomilin
significantly induced GST activity against 4-nitroquinoline 1-oxide (4NQO), intestine (280%) and stomach (75%)
while deacetyl nomilin showed significant induction only in intestine (73%). Induction of GST activity was also
observed in intestine (93%) and stomach (45%) treated with the limonoid mixture. Finally, a significant induction of
NAD(P)H: quinone reductase (QR) activity was observed by the limonoid mixture in stomach (200%). In addition,
the deacetyl nomilin treatment group displayed an increase in QR activity in liver (183%) and intestine (22%).
Conclusion: The results of the present study suggests that, dietary intake of citrus limonoids may provide a
protective effect against the onset of various cancers by inducing the activity of certain phase II detoxifying
enzymes in specific organs.
Background
According to recent studies, chemoprevention may be
achieved by the use of exogenous factors to enhance
endogenous mechanisms that reduce the risk of cancer
development due to exposure to different environmental
factors. Some of these exogenous factors are immuniza-
tions, drugs, supplements and dietary constituents.
Several studies have attributed the biochemical composi-
tion of various fruits and vegetables as instrumental in
reducing the risk of cancer development [1,2]. One
significant mechanism by which this is accomplished is
by the induction of the activity of phase II detoxifying
enzymes by bioactive components of fruits and vegetables
[3,4]. Among these detoxifying enzymes are glutathione
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S-transferase (GST) and NAD(P)H: quinone reductase
(QR). GST isoenzymes are thought to play a crucial phy-
siological role in the initial stages of detoxification of
various xenobiotics including alkylating agents [5].
Generally, an increase in the activity of GST enhances
the ability of an organism to detoxify numerous poten-
tially harmful xenobiotics. It has been reported that sub-
stances that increases the activity of GST can be
potential chemopreventive agents with the ability to inhi-
bit chemically induced cancer formation [6]. Similarly,
QR protects against cytotoxicity by catalyzing a two elec-
tron reduction of quinones that arise from one electron
reduction. Therefore, an increase in the levels QR is posi-
tively correlated with chemoprevention as well [7].
Citrus fruits contain many classes of bioactive com-
pounds that may have the potential to reduce the risk of
cancer [8]. From these, a group of chemically related tri-
terpene derivatives called citrus limonoids are of parti-
cular interest (Figure 1). Many studies, using limonoids,
provided evidence of their protective effects in cancer
prevention, cardiovascular, viral, and other chronic con-
ditions [9-13]. Cell culture studies from our lab resulted
in a promising outcome while evaluating the effect of
limonoids on human cancer cell lines [14-17]. It has
been suggested that one mechanism by which citrus
limonoids are chemopreventive is that the structure of
specific limonoids induce the activity of phase II
enzymes therefore conjugating xenobiotics to produce a
hydrophilic substance that is more readily excreted in
urine [18]. Initial animal studies have begun to evaluate
how limonoids differing in structure may alter phase II
enzymatic activity [9,19-21]. The data presented in this
study further enhances and reinforces current knowl-
edge on the possible chemopreventive properties of
citrus limonoids. In addition, due to the variability in
GST isoenzymes present in various tissues, 4NQO and
CDNB substrates were used in this study to obtain a
more comprehensive picture of the influence of citrus
limonoids on GST activity [9].
The main purpose of this study was to elucidate the
function of various structurally unrelated citrus limonoids
in the induction of phase II enzymes such as GST and QR.
In order to understand structure-activity relationship of
limonoids on biological activity, we analyzed the induction
potential of specific citrus limonoids (Figure 1) with a
closed A ring (nomilin, deacetyl nomilin) and open A ring
Figure 1 Structures of limonoids purified from sour orange and used for the animal experiment.
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(isoobacunoic acid). Furthermore, limonoid mixture
(limonin, nomilin and isoobacunoic acid) was evaluated
for the potential synergistic induction capabilities. The
relationship between the various structural properties of
citrus limonoids and induction of phase II detoxifying
enzymes is vital for understanding the cancer prevention
properties of various agents.
Methods
Materials
Silica gel and solvents were purchased from Fisher
scientific (Pittsburgh, PA). The following chemicals were
purchased from Sigma Aldrich (St. Louis, MO, USA):
b-NADPH reduced tetrasodium salt, 2,6-dichlorophe-
nol-indophenol (DCPIP), 1-chloro-2,4-dinitrobenzene
(CDNB), 4-nitroquinoline 1-oxide (4NQO), glutathione
reduced FAD disodium salt. Bovine Serum Albumin was
obtained from Intergen (Purchase, NY).
Purification of limonoids
Fruits of Citrus aurantium L. were harvested during
October-November from Citrus Center Orchard, Texas
A&M University-Kingsville, TX. Seeds were separated,
air dried at 25°C and powdered using a blender. Seed
powder (2.2 Kg) was defatted with hexane (4 L) and
extracted by Soxhlet with ethyl acetate (4 L) for 8 h. The
extract was filtered and concentrated under vacuum.
This material was infused with silica gel and loaded to
silica gel column chromatography. The column was
eluted with different concentrations of chloroform and
acetone to obtain three potential putative compounds.
Compound (1), (2) and (3) were eluted with chloroform,
chloroform: acetone (9:1) and (5:5) respectively. The
mixture was obtained in between these fractions.
HPLC analysis
The purity of the isolated compounds were analyzed by
HPLC (Perkin Elmer Series pump 2000, Boston, USA)
fitted with C18 Phenomenex Gemini series column
(Torrance, CA, USA), 5 μm particle size, (250 × 4.6
mm) and coupled with a Perkin Elmer Series 2000
Autosampler and a Perkin Elmer Diode Array detector
235C. The gradient mobile phase consisted of 0.03 mM
phosphoric acid (A) and acetonitrile (B) with the flow
rate of 1.0 ml/min. The elution program involved a lin-
ear gradient from 5 to 50% B in A for 0-38 min and 5%
B in A for 35-43 min followed by 5 min of equilibrium
with 5% B. The eluted compounds were detected by
their absorbance at 210 nm. The purity of the com-
pounds and mixture composition was analyzed accord-
ing to our published methods [6,22]. Further structures
of the isolated compounds were confirmed by spectro-
scopic methods and results were compared to our pub-
lished papers [7-9,22].
Animal studies
Female A/JOlaHsd 8-9 weeks old mice were purchased
from Harlan Sprague-Dawley Laboratory (Indianapolis,
IN). Procedures, recommended by the federal agencies
and approved by the University of Texas-Pan American
Institutional Animal Care and Use committee were
followed for animal handling, treatment, and euthanasia.
The mice were fed AIN-76 semi-purified custom diet
without vitamin E (MPBiomedical, Solon, OH) and tap
water ad libitum. The mice were kept in plastic cages in
an environmentally controlled room on a 12 h light/12 h
dark cycle.
The mice were divided into four experimental groups
and one control group. Each group consisting of four
mice (n = 4). The experimental groups were treated with
nomilin, deacetyl nomilin, isoobacunoic acid and a limo-
noid mixture consisting of limonin, nomilin, and isooba-
cunoic acid. Each treatment (20 mg) was suspended in
DMSO: corn oil (1:1) (v/v) and administered by oral
gavage once every two days. The control group was given
the corresponding DMSO: corn oil (1:1) treatment. The
total treatment was composed of four administrations for
each of the compounds being investigated. Forty-eight
hours after the last treatment the mice were sacrificed by
cervical dislocation. Lung, small intestine, whole sto-
mach, and liver were harvested immediately after sacri-
fice and washed with cold PBS. Excised tissues were
weighed and homogenized using a Pro200 homogenizer
with PBS (10 mM), pH 7.0, containing b-mercaptoetha-
nol (1.4 mM) to obtain a 10% (w/v) homogenate. The cell
extracts were centrifuged at 22,000 × g for 45 min in a
refrigerated Beckman Avanti 30 centrifuge. Following
centrifugation, the supernatant was carefully removed
and stored at -20°C until further use.
Determination of enzyme activities and protein
GST activity was determined using CDNB by the modi-
fied method from previous publications [23,24]. This
system involves the addition of GSH to CDNB, a
nucleophilic aromatic substitution that occurs via an
addition-elimination sequence involving a short lived
s-complex intermediate [25]. In addition, GST activity
determination using 4NQO was also evaluated in order
to explore induction of different GST isoenzymes in dif-
ferent organs. This assay is modeled after the method
developed by Stanley et al [26]. Furthermore, an assay
for the examination of QR activity was employed for
evaluating the potential of limonoids to induce activity.
The QR assay was adapted from the method reported
by Wang et al. [27]. Detail for all assays performed can
be referred to in our previous publications [9].
All enzyme assays were performed using a spectro-
photometer equipped with enzyme kinetic software and
programmed to calculate enzyme units. The amount of
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enzyme that used 1 μmole of substrate per minute at
25°C is equivalent to one unit of enzyme activity. The
protein contents of the samples were quantified by
Bradford’s method [28]. The absorbance was read at 595
nm. Bovine serum albumin was used as a standard.
Each organ homogenate represented one sample from
individual mice; all assays were performed in triplicates.
Student’s t-test was used to assess the significance
of the data. P-values of p < 0.05 were considered
significant.
Results
Purification of ethyl acetate extract of Citrus aurantium
yielded three compounds (1, 2, and 3) and a mixture.
The purity of the isolated compounds and composition
of the mixture were analyzed by HPLC as per our
previous method [22] and the chromatograms have been
presented in Figure 2. The mixture contains limonin
(87.1%), nomilin (7.1%) and isoobacunoic acid (3.8%).
Further, structures of the pure compounds (1, 2 and 3)
were identified as nomilin, isoobacunoic acid and deace-
tyl nomilin respectively by NMR studies and chemical
shifts were compared with our published data [7-9,29].
The biological effect of three limonoids and the mixture
of limonoids were investigated on four organs of female
A/J mice on the induction of GST activity (Table 1).
Among the limonoids tested, the highest induction of
GST was observed against CDNB by nomilin (58%), fol-
lowed by isoobacunoic acid (25%) and deacetyl nomilin
(19%) in stomach. Interestingly, deacetlylnomilin in intes-
tine as well as in liver demonstrated significant reduction
of GST activity. Furthermore the mixture of limonoids
and isoobacunoic acid in liver also demonstrated signifi-
cant reduction of GST against CDNB. No significant
changes were observed in any of the treatment groups in
lung homogenates.
GST activity was measured against 4NQO, in four
organs mentioned earlier and the results are presented
in Table 2. The most noticeable induction of GST activ-
ity against 4NQO was observed in intestine homoge-
nates compared to control. Nomilin showed significant
induction of GST in intestine (280%), followed by the
limonoid mixture (93%) and deacetyl nomilin (73%) also
induced GST activity in intestine homogenates. In
stomach homogenates, nomilin and the limonoid mix-
ture significantly (p < 0.05) induced GST activity, 75%
and 45% respectively, against 4NQO. In the other
organs, lung and liver, no significant changes were
observed.
Table 3 depicts quinone reductase (QR) activity in
liver, intestine, lung and stomach homogenates. In sto-
mach homogenates, significant induction of QR activity
was observed using limonoid mixture (200%) treatment
group. Deacetyl nomilin also showed QR induction in
liver (180%) and intestine (22%) homogenates. Similar to
GST, none of the limonoids significantly induced QR
activity in lung homogenates. Isoobacunoic acid, how-
ever, showed significant reduction of QR activity com-
pared to the control in stomach.
Discussion
Recent research on citrus limonoids has specifically
focused on isolation, elucidation of structures, and the
effects of these compounds on different biological
systems [9-16,29-32]. One focal point in citrus limonoid
research has been on their ability to induce the activity
of phase II detoxification enzymes. A recent study by
Wark et al. suggests that habitual consumption of fruits
and vegetables positively correlated with human rectal
GST activity [33]. It is thus possible that an increase in
the activity of phase II enzymes enhances the ability of
an organism to effectively detoxify carcinogens. There-
fore, any substance that increases the activity of phase II
enzymes may be a potential chemopreventive agent with
the ability to inhibit chemically induced cancer forma-
tion [21]. Several studies have attributed the induction
of these enzymes to the structural components of limo-
noids. The furan moiety has been thought to be one of
the components responsible for induction of GST activ-
ity [21]. Lam et al. [34] studied two furan containing
diterpenes, kahweol and cafestol, which were shown to
induce an increase in the activity GST in various tissues
in mice. In a later study, eight citrus limonoids were
tested for induction of GST activity in mice and the
structural features of different citrus limonoids and their
effect on GST activity was reported [21]. Other struc-
tural features that seem to play a role in the induction
of GST activity are the A and A’ rings, and modification
to the B ring in limonoids [9,21].
Quinone reductase activity has also been observed
along with other phase II enzymes [35]. QR protects
against cytotoxicity, and an increase in its levels is posi-
tively correlated with chemoprevention. QR levels
increased along with the levels of other chemopreventive
enzymes which were induced by chemicals with diverse
functional groups [35]. QR catalyses the two electron
reduction of quinones to protect cells from free radicals
and reactive oxygen species that arise from one electron
reduction [36]. In a previous study, nimbolide, a limo-
noid isolated from neem flowers, showed induction of
QR activity in Hepa1c1c7 cells [37].
In our study, nomilin, which is composed of intact A,
B, C, and D rings showed the highest induction activity
in the GST assays. Results from this study and previous
studies consistently exhibited nomilin as an inducer of
GST [19,21] It is possible that, nomilin possesses most
of the structural features that are reported to be essen-
tial in the induction of GST activity. Deacetyl nomilin
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Figure 2 HPLC profile of limonoids and a mixture obtained from sour oranges.
Table 1 GST Specific activity against 1-chloro-2,4-dinitrobenzene, CDNB (Specific activity expressed as units/mg
protein)
Samples Stomach Intestine Liver Lung
Control 0.728 ± 0.05 1.260 ± 0.13 2.520 ± 0.11 0.399 ± 0.07
Mixture 0.757 ± 0.02 1.191 ± 0.11 1.833 ± 0.26* 0.414 ± 0.02
Nomilin 1.152 ± 0.16** 1.122 ± 0.24 2.223 ± 0.39 0.395 ± 0.01
Deacetyl nomilin 0.872 ± 0.09** 0.715 ± 0.18* 1.582 ± 0.24* 0.449 ± 0.01
Isoobacunoic Acid 0.914 ± 0.13** 0.825 ± 0.84 1.390 ± 0.02* 0.365 ± 0.01
Results are means ± SD (n = 4).
* indicates statistically significant (p < 0.05) reduction of activity.
** indicates statistically significant (p < 0.01) induction of activity.
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has a structural similarity to nomilin with the exception
of the deacetylation of the A ring (Figure 1). Deacetyl
nomilin induced GST in some organs, while also indu-
cing QR activity in liver and intestine. These results
reinforces our observation that the composition of the
A ring seems to be critical for the induction of phase II
enzymes.
Isoobacunoic acid has an intact A’ ring and an open A
ring, while the rest of the limonoid structure is similar to
nomilin. Isoobacunoic acid induced GST activity against
CDNB was only observed in stomach homogenates. It is
interesting that induction of GST activity was observed
even in the absence of an intact A ring (Table 1). It is
therefore possible that other structural components of
limonoids structure may influence enzyme induction.
The limonoid mixture used in this study induced GST
activity against 4NQO in stomach and liver homoge-
nates and induction of QR activity was observed in sto-
mach homogenates (Table 3). The limonoid mixture
was composed of limonin (87.1%), nomilin (7.1%), and
isoobacunoic acid (3.8%). In previous studies [9,21], it
was concluded that limonin was ineffective as a GST
inducer. This was attributed to the fact that the struc-
ture of limonin is composed of intact A and A’ rings. In
the current study, the ability of the limonoid mixture to
induce GST activity was probably due to the presence of
nomilin in the mixture. It is likely that minor compo-
nents of the mixture possibly have some biological
attributes.
In this study, none of the limonoids or mixture
had effect on GST or QR activity in the lung. This
phenomenon could be due to the fact that the composi-
tion of GST isoenzymes varies in mammalian tissues.
Previous reports suggest that variability of GST isoen-
zymes is influenced by tissue, species, and gender
[38-40]. Most major mammalian GST isoenzymes are
grouped into four major classes namely, a, μ, π and
θ [41]. Accumulating evidences suggest that certain
citrus limonoids can induce detoxifying enzymes, mainly
GST [9-12,19-21]. In majority of these studies, nomilin
seems to be the strongest inducer of GST activity
against CDNB. During evaluation of induction of GST
activity, CDNB was used as a general substrate, which
did not reveal any substrate preference for any of the
three major GST isozymes a, μ, π [42]. A later study
showed that the specific activity of a, μ, π isozymes var-
ied widely when CDNB was used as a substrate [43].
One study suggests that the GST μ isoenzyme is more
efficient in the conjugation of 4-nitroquinoline 1-oxide
(4NQO) [44]. Furthermore, it was also demonstrated
that one of the GST isoenzymes in stomach is efficient
in the conjugation of glutathione but was not detected
in lung homogenate from A/J female mouse [39]. Other
studies suggested that the gender of the organism may
also influence isoenzyme composition along with GST
differences among tissues [39]. It is therefore possible
that the lack of induction of GST activity in lung by
citrus limonoids may be due to the fact that the induced
GST isoenzymes, if any, were not specific for CDNB
conjugation.
In addition to the inactivity of limonoid in lung homo-
genates, certain limonoids showed reduction of GST
Table 2 GST Specific Activity against 4-Nitroquinoline 1-oxide (Specific activity expressed as units/mg of protein)
Samples Stomach Intestine Liver Lung
Control 0.519 ± 0.06 0.322 ± 0.06 1.720 ± 0.34 0.414 ± 0.19
Mixture 0.755 ± 0.04** 0.624 ± 0.18** 1.765 ± 0.40 0.426 ± 0.04
Nomilin 0.927 ± 0.12** 0.905 ± 0.13** 2.045 ± 0.25 0.351 ± 0.08
Deacetyl nomilin 0.594 ± 0.12 0.558 ± 0.17 ** 1.551 ± 0.30 0.431 ± 0.04
Isoobacunoic Acid 0.592 ± 0.02 0.604 ± 0.57 1.179 ± 0.05 0.374 ± 0.02
Results are means ± SD (n = 4).
* indicate statistically significant (p < 0.05) reduction of QR activity was observed.
** indicate statistically significant (p < 0.01) induction of QR activity was observed.
Table 3 Quinone Reductase Specific Activity (Specific activity expressed as units/mg of protein)
Samples Stomach Intestine Liver Lung
Control 6.592 ± 0.60 3.838 ± 0.54 0.618 ± 0.06 0.377 ± 0.12
Mixture 13.372 ± 4.17** 3.544 ± 0.92 0.623 ± 0.10 0.374 ± 0.05
Nomilin 6.226 ± 0. 71 2.892 ± 0.43 0.662 ± 0.17 0.354 ± 0.02
Deacetyl nomilin 6.113 ± 2.12 4.702 ± 0.43** 1.137 ± 0.36** 0.356 ± 0.04
Isoobacunoic Acid 4.982 ± 1.19* 3.229 ± 2.57 1.477 ± 0.78 0.349 ± 0.03
Results are means ± SD (n = 4).
* indicate statistically significant (p < 0.05) reduction of QR activity was observed
** indicate statistically significant (p < 0.01) induction of QR activity was observed.
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activity in different organs. Previous studies have shown
that GST activity can be inhibited, reversibly and irre-
versibly by various compounds [45]. It has been pro-
posed that possible inhibition mechanisms are the
covalent bonding of compounds to the GST enzyme,
competitive inhibition against CDNB, and noncompeti-
tive inhibition against GSH [46-48]. The inhibition of
GST could prevent the possible inactivation of che-
motherapeutic drugs and thus could be beneficial for
chemotherapeutic reason [49].
Conclusion
In this study, the citrus limonoids have shown specific
induction of GST and QR with one or more substrates.
The induction of these enzymes illustrates the potential
chemopreventive role of citrus limonoids. It is possible
that, an adequate intake of citrus fruit may detoxify
phase II enzymes in the body, which may have potential
benefits in prevention of cancer and other xenobiotic
related diseases. Further studies are needed to determine
how these limonoids might be reducing phase II enzyme
activity.
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